BioXcel Therapeutics BTAI Growth Metrics (2018-2026)

NASDAQ BTAI
$0.04 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT
Reported Financials

BioXcel Therapeutics Quarterly Growth Metrics

Periods 33 quarters
Latest Jun 2026

BioXcel Therapeutics growth metrics data for the quarter ended Jun 2026. These growth metrics cover 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
EBITDA Margin Growth (1y)
1.43M1.69M2.07M0.99M0.70M0.24M-0.19M-1.16M-0.74M-0.11M0.10M0.76M
EBITDA Margin Growth (3y)
1.39M1.82M1.99M0.59M
EBITDA Margin (QoQ)
0.62M-0.26M1.34M-0.27M0.89M0.11M0.26M-0.56M0.43M-0.31M-0.72M-0.13M1.05M-0.09M-0.06M
EBIT Margin Growth (1y)
1.43M1.69M2.07M0.99M0.70M0.24M-0.19M-1.16M-0.74M-0.11M0.10M0.76M
EBIT Margin Growth (3y)
1.39M1.82M1.99M0.59M
EBIT Margin (QoQ)
0.62M-0.26M1.34M-0.27M0.89M0.11M0.26M-0.56M0.43M-0.31M-0.72M-0.13M1.05M-0.09M-0.06M
EBT Margin Growth (1y)
1.58M1.69M2.09M1.00M0.62M0.21M-0.36M-1.47M-1.01M-0.17M0.13M0.87M
EBT Margin Growth (3y)
1.18M1.72M1.86M0.40M
EBT Margin (QoQ)
0.77M-0.27M1.37M-0.30M0.89M0.13M0.28M-0.68M0.48M-0.44M-0.83M-0.22M1.31M-0.13M-0.10M
FCF Margin Growth (1y)
1.17M0.91M2.24M0.63M0.34M0.31M-0.41M-0.84M-1.15M-0.15M0.14M0.71M
FCF Margin Growth (3y)
0.36M1.07M1.97M0.50M
FCF Margin (QoQ)
0.65M-0.92M1.71M-0.27M0.39M0.41M0.09M-0.55M0.36M-0.31M-0.33M-0.87M1.36M-0.02M0.24M
Gross Margin Growth (1y)
-0.01M-0.02M-938.007.00-0.04M-0.00M541.00-0.01M0.05M0.02M-0.01M0.01M
Gross Margin Growth (3y)
-320.00-872.00-0.01M-640.00
Gross Margin (QoQ)
425.00-59.00-132.00-0.01M-0.00M0.02M813.00-0.05M0.03M0.02M-0.01M0.01M-128.00-0.01M0.01M
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
50.79%17.43%-19.34%98.67%99.57%99.58%99.66%29.71%-40.93%68.06%55.95%70.93%72.83%55.02%62.25%19.68%19.37%10.12%3.72%36.23%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
72.51%-27.20%81.74%79.20%85.58%89.69%87.89%86.06%88.17%91.58%91.75%45.25%32.41%49.46%45.69%47.00%
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y)
61.97%-14.97%74.82%70.86%76.91%78.65%76.98%73.18%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
-41.24%-78.68%-3.26%99.49%53.94%-71.90%16.06%-5.77%7.66%61.04%-15.78%30.22%13.68%35.51%2.81%-48.45%13.34%28.11%-4.12%1.68%
Net Margin Growth (1y)
1.58M1.69M2.09M1.00M0.62M0.21M-0.36M-1.47M-1.01M-0.17M0.13M0.87M
Net Margin Growth (3y)
1.18M1.72M1.86M0.40M
Net Margin (QoQ)
0.77M-0.27M1.37M-0.30M0.89M0.13M0.28M-0.68M0.48M-0.44M-0.83M-0.22M1.31M-0.13M-0.10M
Operating Margin Growth (1y)
1.43M1.69M2.07M0.99M0.70M0.24M-0.19M-1.16M-0.74M-0.11M0.10M0.76M
Operating Margin Growth (3y)
1.39M1.82M1.99M0.59M
Operating Margin (QoQ)
0.62M-0.26M1.34M-0.27M0.89M0.11M0.26M-0.56M0.43M-0.31M-0.72M-0.13M1.05M-0.09M-0.06M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
727.00-687.00-517.00-0.00M-0.00M-0.00M-0.00M-0.01M-0.01M-0.01M-0.01M-0.00M0.00M0.00M0.00M-0.00M-0.00M0.00M444.000.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-786.00-54.00319.000.00M0.00M893.00-0.00M-0.01M-0.01M-0.02M-0.02M-0.01M-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.01M-0.01M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M
Return on Assets [ROA] (QoQ)ROA (QoQ)
390.00-513.00-703.00-342.00-246.00-0.00M-0.00M-0.00M-0.00M-0.00M904.000.00M851.00-0.00M928.00-0.00M0.00M0.00M-0.00M-0.00M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.00M-792.00-619.00-0.00M-0.00M-0.00M-0.01M-0.01M-0.02M-0.02M-0.02M-0.01M0.00M-0.00M-0.01M0.46M0.23M0.09M0.07M-0.43M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-776.00288.000.00M0.00M0.00M0.00M-0.00M-0.01M-0.02M-0.02M-0.03M-0.02M-0.02M-0.03M-0.04M0.44M0.21M0.06M0.04M0.02M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
-0.01M-0.01M-0.02M-0.02M-0.02M-0.01M-0.01M-0.02M-0.03M0.44M0.21M0.06M0.04M0.01M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
403.00-605.00-779.00-404.00-197.00-0.00M-0.00M-0.00M-0.01M-0.00M-0.00M0.01M-714.00-0.01M-0.01M0.47M-0.23M-0.15M-0.02M-0.03M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
1.43M1.69M2.07M0.99M0.70M0.24M-0.19M-1.16M-0.74M-0.11M0.10M0.76M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
1.39M1.82M1.99M0.59M
Return on Sales [ROS] (QoQ)ROS (QoQ)
0.62M-0.26M1.34M-0.27M0.89M0.11M0.26M-0.56M0.43M-0.31M-0.72M-0.13M1.05M-0.09M-0.06M